Atlas Trials

Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)

Clinical trial NCT00343083 · COMPLETED

Trial details

NCT number
NCT00343083
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer of Head and Neck
Start date
2004-12-01
Primary completion
2011-06-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.